Salbutamol | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Salbutamol
US Patents

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

Contact Supplier

pharmacompass-1-m-2025-11-24

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

Contact Supplier

pharmacompass-2-m-2025-11-03

Salbutamol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

72 API Suppliers, 28 USDMF, 12 CEP/COS, 1 JDMF, 11 EU WC, 2 KDMF, 23 NDC API, 39 Listed Suppliers, $ API Reference Price

72 API Suppliers
28 USDMF
12 CEP/COS
1 JDMF
11 EU WC
2 KDMF
23 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

190 Drugs in Development

190 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

428 FDF Dossiers, 135 FDA Orange Book, 149 Europe, 20 Canada, 16 Australia, 43 South Africa, 65 Listed Dossiers

428 FDF Dossiers
135 FDA Orange Book
149 Europe
20 Canada
16 Australia
43 South Africa
65 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH, AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH
SOLUTION;INHALATION - EQ 0.083% BASE;0.017% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH
AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 5 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 6 Kirsch Pharma, 1 ACG Worldwide, 11 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 CD Formulation, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Esteem Industries, 3 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 3 Ingredion Pharma Solutions, 23 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 26 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 27 Thickeners and Stabilizers, 26 Direct Compression, 25 Granulation, 24 Controlled & Modified Release, 19 Taste Masking, 18 Film Formers & Plasticizers, 17 Disintegrants & Superdisintegrants, 16 Lubricants & Glidants, 16 Topical, 13 Parenteral, 11 Co-Processed Excipients, 10 Solubilizers, 9 Chewable & Orodispersible Aids, 7 Rheology Modifiers, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin, 1 Surfactant & Foaming Agents

48 Fillers, Diluents & Binders
45 Coating Systems & Additives
27 Thickeners and Stabilizers
26 Direct Compression
25 Granulation
24 Controlled & Modified Release
19 Taste Masking
18 Film Formers & Plasticizers
17 Disintegrants & Superdisintegrants
16 Lubricants & Glidants
16 Topical
13 Parenteral
11 Co-Processed Excipients
10 Solubilizers
9 Chewable & Orodispersible Aids
7 Rheology Modifiers
7 Emulsifying Agents
5 Empty Capsules
5 API Stability Enhancers
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 94 News #PharmaBuzz

1 Data Compilation #PharmaFlow
94 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 83 Regulatory FDF Prices, 21 Annual Reports

38 US Medicaid Prescriptions
83 Regulatory FDF Prices
21 Annual Reports

MARKET PLACE

33 APIs, 14 FDF Dossiers, 1 EXCIPIENTS

33 APIs
14 FDF Dossiers
1 EXCIPIENTS

PATENTS & EXCLUSIVITIES

36 US Patents, 4 Health Canada Patents

36 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 31 Others

5 EDQM
31 Others

$ API Ref.Price (USD/KG) : 146 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4BOEHRINGER INGELHEIM

filter Patent Number Reset all filters

4 All

01 17396341

02 17837235

03 18733341

04 19027967

API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 12026-10-10

02 12027-03-31

03 12028-03-13

04 12030-10-16

Product Main Page

01

BOEHRINGER INGELHEIM

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

CTAD25

Not Confirmed

BOEHRINGER INGELHEIM

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-10-10

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

US Patent Number : 7396341

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21747

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2026-10-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BOEHRINGER INGELHEIM

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

CTAD25

Not Confirmed

BOEHRINGER INGELHEIM

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-03-13

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

US Patent Number : 7837235

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21747

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2028-03-13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

BOEHRINGER INGELHEIM

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

CTAD25

Not Confirmed

BOEHRINGER INGELHEIM

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-10-16

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

US Patent Number : 8733341

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21747

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2030-10-16

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

BOEHRINGER INGELHEIM

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

CTAD25

Not Confirmed

BOEHRINGER INGELHEIM

CTAD25

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-03-31

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

US Patent Number : 9027967

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 21747

Patent Use Code :

Delist Requested : Y

Patent Use Description :

Patent Expiration Date : 2027-03-31

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!